SK Biopharm, IPO Price Set at 49,000 Won... Market Capitalization of 3.8 Trillion Won

[Asia Economy Reporter Hyungsoo Park] SK Biopharm has set the public offering price at 49,000 KRW following a two-day demand forecast conducted from the 17th to the 18th targeting domestic and overseas institutional investors.

SK Biopharm announced on the 20th that 1,076 institutions participated in the demand forecast for 11.75 million shares, which is 60% of the total public offering volume, recording a competition rate of 835.66 to 1.

The desired price range for the public offering was 36,000 to 49,000 KRW. Based on the demand forecast results, the public offering price was finalized at the upper end of the band, 49,000 KRW. The total public offering amount was confirmed at 959.3 billion KRW. The market capitalization based on the public offering price is approximately 3.8373 trillion KRW.

SK Biopharm will conduct public subscription for general investors over two days on the 23rd and 24th. It will be listed on the KOSPI market on the 2nd of next month.

This content was produced with the assistance of AI translation services.